SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

72,638.70 -429.11
( -0.59%)

Global Indices

Nasdaq

51,551.76 262.86
(0.51%)

Dow Jones

7,841.47 46.52
(0.60%)

Hang Seng

70,229.08 -454.90
(-0.64%)

Nikkei 225

10,543.25 45.31
(0.43%)

Forex

USD-INR

96.27 0.31
(0.32%)

EUR-INR

107.88 -0.09
(-0.09%)

GBP-INR

127.24 0.23
(0.18%)

JPY-INR

0.61 0.00
(0.27%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Natco Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524816

INE987B01026

501.202063

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

NATCOPHARM

18.12

16158.35

EPS(TTM)

Face Value()

Div & Yield %

45.47

0.55

Back

Natco Pharma announces conclusion of USFDA inspection of its Visakhapatnam unit

Aug 22,2026

Natco Pharma announced conclusion of US FDA Inspection at its Visakhapatnam, Andhra Pradesh, Finished Dosage Formulations (FDF) Unit. The inspection was conducted from 17 August to 21 August 2026.

Upon conclusion of the inspection, the Company has been issued a Form 483 with 4 (Four) observations.

72,638.70 -429.11 ( -0.59%)

51,551.76 262.86 (0.51%)

7,841.47 46.52 (0.60%)

70,229.08 -454.90 (-0.64%)

10,543.25 45.31 (0.43%)

96.27 0.31 (0.32%)

107.88 -0.09 (-0.09%)

127.24 0.23 (0.18%)

0.61 0.00 (0.27%)